0001181431-12-055804.txt : 20121029
0001181431-12-055804.hdr.sgml : 20121029
20121029215347
ACCESSION NUMBER: 0001181431-12-055804
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20121026
FILED AS OF DATE: 20121029
DATE AS OF CHANGE: 20121029
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ANDO DALE G
CENTRAL INDEX KEY: 0001202278
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30171
FILM NUMBER: 121167810
MAIL ADDRESS:
STREET 1: C/O CELL GENESYS INC
STREET 2: 500 FORBES BLVD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SANGAMO BIOSCIENCES INC
CENTRAL INDEX KEY: 0001001233
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 680359556
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 501 CANAL BLVD
STREET 2: POINT RICHMOND TECH CNTR.
CITY: RICHMOND
STATE: CA
ZIP: 94804
BUSINESS PHONE: 5109706000
MAIL ADDRESS:
STREET 1: 501 CANAL BLVD
STREET 2: POINT RICHMOND TECH CNTR.
CITY: RICHMOND
STATE: CA
ZIP: 94804
4
1
rrd358936.xml
FORM 4
X0306
4
2012-10-26
0
0001001233
SANGAMO BIOSCIENCES INC
SGMO
0001202278
ANDO DALE G
C/O SANGAMO BIOSCIENCES INC.
POINT RICHMOND TECH CNTR, 501 CANAL BLVD
RICHMOND
CA
94804
0
1
0
0
VP, Therapeutic Dev. & CMO
Common Stock
2012-10-26
4
M
0
15000
3.61
D
78534
D
Common Stock
2012-10-26
4
S
0
15000
5.689
D
63534
D
Common Stock
2012-10-26
4
S
0
5000
5.720
D
58534
D
Employee Stock Option (Right to Buy)
3.61
2012-10-26
4
M
0
15000
0
D
2014-08-01
Common Stock
15000
65800
D
The sales reported in this Form 4 were effected pursuant to the Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2012, amended on September 12, 2012.
The price reported in Column 4 is a weighted average price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.60 to $5.94, inclusive. The reporting person undertakes to provide to Sangamo Biosciences Inc., any security holder of Sangamo Biosciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
These shares were sold in multiple transactions at prices ranging from $5.58 to $5.9155, inclusive.
All shares underlying this option are vested and immediately exercisable.
/s/ Dale G. Ando
2012-10-29